OTCPK:SONV.Y

Stock Analysis Report

Executive Summary

Sonova Holding AG designs, develops, manufactures, and distributes hearing systems for adults and children with hearing impairment.

Snowflake

Fundamentals

Excellent balance sheet average dividend payer.


Similar Companies

Share Price & News

How has Sonova Holding's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-4.7%

OTCPK:SONV.Y

-1.2%

US Medical Equipment

1.2%

US Market


1 Year Return

6.2%

OTCPK:SONV.Y

8.7%

US Medical Equipment

1.7%

US Market

SONV.Y underperformed the Medical Equipment industry which returned 8.7% over the past year.

SONV.Y outperformed the Market in United States of America which returned 1.7% over the past year.


Share holder returns

SONV.YIndustryMarket
7 Day-4.7%-1.2%1.2%
30 Day-3.8%1.4%4.9%
90 Day-4.7%4.8%3.7%
1 Year6.9%6.2%9.6%8.7%3.9%1.7%
3 Year62.8%59.0%70.8%65.5%47.2%37.7%
5 Year44.4%38.4%130.4%104.1%60.0%42.4%

Price Volatility Vs. Market

How volatile is Sonova Holding's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Sonova Holding undervalued based on future cash flows and its price relative to the stock market?

31.24x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

Sonova Holding's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

Sonova Holding's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

Sonova Holding is good value based on earnings compared to the US Medical Equipment industry average.

Sonova Holding is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

Sonova Holding is poor value based on expected growth next year.


Price Based on Value of Assets

Sonova Holding is overvalued based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is Sonova Holding expected to perform in the next 1 to 3 years based on estimates from 18 analysts?

8.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Sonova Holding's revenue is expected to grow by 6.3% yearly, however this is not considered high growth (20% yearly).

Sonova Holding's earnings are expected to grow by 8.9% yearly, however this is not considered high growth (20% yearly).

Sonova Holding's revenue growth is positive but not above the United States of America market average.

Sonova Holding's earnings growth is positive but not above the United States of America market average.

Sonova Holding's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Sonova Holding is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).


Next Steps

Past Performance

How has Sonova Holding performed over the past 5 years?

4.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Sonova Holding's year on year earnings growth rate has been positive over the past 5 years.

Sonova Holding's 1-year earnings growth exceeds its 5-year average (13.5% vs 4.9%)

Sonova Holding's earnings growth has not exceeded the US Medical Equipment industry average in the past year (13.5% vs 28.9%).


Return on Equity

Sonova Holding has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

Sonova Holding used its assets more efficiently than the US Medical Equipment industry average last year based on Return on Assets.


Return on Capital Employed

Sonova Holding's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is Sonova Holding's financial position?


Financial Position Analysis

Sonova Holding is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Sonova Holding's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Sonova Holding's level of debt (25.7%) compared to net worth is satisfactory (less than 40%).

The level of debt compared to net worth has increased over the past 5 years (4.5% vs 25.7% today).

Debt is well covered by operating cash flow (87.4%, greater than 20% of total debt).

Interest payments on debt are well covered by earnings (EBIT is 5438x coverage).


Balance Sheet

Low level of unsold assets.

Debt is covered by short term assets, assets are 2.2x debt.


Next Steps

Dividend

What is Sonova Holding's current dividend yield, its reliability and sustainability?

1.68%

Expected Dividend Yield


Dividend Yield and Payments Analysis

Sonova Holding's pays a lower dividend yield than the bottom 25% of dividend payers in United States of America (1.45%).

Sonova Holding's dividend is below the markets top 25% of dividend payers in United States of America (3.67%).

Dividends per share have been stable in the past 10 years.

Dividends per share have increased over the past 10 years.


Current Payout to Shareholders

Dividends paid are well covered by earnings (2.4x coverage).


Future Payout to Shareholders

Dividends after 3 years are expected to be well covered by earnings (2.6x coverage).


Next Steps

Management

What is the CEO of Sonova Holding's salary, the management and board of directors tenure and is there insider trading?

3.9yrs

Average management tenure


CEO

Arnd Kaldowski (52yo)

1.4yrs

Tenure

CHF3,331,472

Compensation

Mr. Arnd Kaldowski has been the Chief Executive Officer at Sonova Holding AG since April 1, 2018 and its Chief Operating Officer since October 1, 2017 and its Member of Management Board since October 1, 20 ...


CEO Compensation Analysis

Arnd's remuneration is lower than average for companies of similar size in United States of America.

Arnd's compensation has been consistent with company performance over the past year, both up more than 20%.


Management Age and Tenure

3.9yrs

Average Tenure

53yo

Average Age

The tenure for the Sonova Holding management team is about average.


Board Age and Tenure

6.8yrs

Average Tenure

62.5yo

Average Age

The tenure for the Sonova Holding board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Hans Mehl (60yo)

    Executive Officer

    • Tenure: 12.4yrs
  • Arnd Kaldowski (52yo)

    CEO, COO & Member of Management Board

    • Tenure: 1.4yrs
    • Compensation: CHF3.33m
  • Hartwig Grevener (53yo)

    CFO & Member of Management Board

    • Tenure: 7.1yrs
  • Hansjürg Emch (51yo)

    Strategic Advisor to AB

    • Tenure: 0.4yrs
  • Andi Vonlanthen (58yo)

    Group VP of Research & Development and Member of Management Board

    • Tenure: 7.4yrs
  • Claude Diversi (55yo)

    Group VP of Hearing Instruments Wholesale & Member of Management Board

    • Tenure: 7.3yrs
  • Martin Grieder (54yo)

    Group VP of Hearing Instruments Marketing & Member of Management Board

    • Tenure: 5.1yrs
  • Vicky Carr-Brendel

    Member of Management Board

    • Tenure: 0.4yrs
  • Christophe Fond (53yo)

    Group VP of Audiological Care & Member of Management Board

    • Tenure: 2.7yrs
  • Claudio Bartesaghi (46yo)

    Group VP of Corporate HRM & Communications and Member of Management Board

    • Tenure: 1.9yrs

Board Members

  • Robert Spoerry (64yo)

    Chairman

    • Tenure: 8.5yrs
    • Compensation: CHF957.13k
  • Michael Jacobi (66yo)

    Non-Executive Director

    • Tenure: 16.7yrs
    • Compensation: CHF350.07k
  • Beat Hess (70yo)

    Vice Chairman

    • Tenure: 7.3yrs
    • Compensation: CHF347.42k
  • Stacy Seng (55yo)

    Non-Executive Director

    • Tenure: 5.7yrs
    • Compensation: CHF334.58k
  • Jinlong Wang (62yo)

    Non-Executive Director

    • Tenure: 6.3yrs
    • Compensation: CHF324.44k
  • Lukas Braunschweiler (63yo)

    Director

    • Tenure: 1.3yrs
    • Compensation: CHF440.98k
  • Ronald van der Vis (52yo)

    Non-Executive Director

    • Tenure: 10.3yrs
    • Compensation: CHF334.58k
  • Lynn Bleil (56yo)

    Non-Executive Director

    • Tenure: 3.3yrs
    • Compensation: CHF332.44k

Company Information

Sonova Holding AG's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Sonova Holding AG
  • Ticker: SONV.Y
  • Exchange: OTCPK
  • Founded: 1947
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: CHF14.031b
  • Listing Market Cap: CHF14.185b
  • Shares outstanding: 64.36m
  • Website: https://www.sonova.com

Number of Employees


Location

  • Sonova Holding AG
  • Laubisrutistrasse 28
  • Stäfa
  • Zurich
  • 8712
  • Switzerland

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
PHBNDB (Deutsche Boerse AG)YesRegistered SharesDEEURDec 1994
SOONSWX (SIX Swiss Exchange)YesRegistered SharesCHCHFDec 1994
SONV.FOTCPK (Pink Sheets LLC)YesRegistered SharesUSUSDDec 1994
0QPYLSE (London Stock Exchange)YesRegistered SharesGBCHFDec 1994
SONV.YOTCPK (Pink Sheets LLC)UNSPONSORED ADRUSUSDDec 2008
PHBADB (Deutsche Boerse AG)UNSPONSORED ADRDEEURDec 2008
SOONESWX (SIX Swiss Exchange)CHF0.05(2ND LINE)CHCHFDec 2014
SOONESWX (SIX Swiss Exchange)CHF0.05CHCHFOct 2018

Biography

Sonova Holding AG designs, develops, manufactures, and distributes hearing systems for adults and children with hearing impairment. It offers hearing instruments, cochlear implants, wireless communication  ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/15 00:34
End of Day Share Price2019/09/13 00:00
Earnings2019/03/31
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.